Seelos Therapeutics, Inc. (SEELQ) — Working Capital to Net Assets Ratio
Seelos Therapeutics, Inc. (SEELQ) has a Working Capital to Net Assets ratio of 100.2% as of June 2024. Working capital of $-28.18 Million (current assets of $2.33 Million minus current liabilities of $30.51 Million) is measured against net assets of $-28.13 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how financially flexible is Seelos Therapeutics, Inc. to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Seelos Therapeutics, Inc. Working Capital to Net Assets (2020–2023)
This chart shows how Seelos Therapeutics, Inc.'s Working Capital to Net Assets ratio has evolved across 4 annual periods from 2020 to 2023. As of June 2024, the ratio stands at 100.2%, reflecting working capital of $-28.18 Million against net assets of $-28.13 Million USD. See SEELQ cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Seelos Therapeutics, Inc. (2020–2023)
The table below presents the year-by-year Working Capital to Net Assets ratio for Seelos Therapeutics, Inc. from 2020 to 2023, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Seelos Therapeutics, Inc. stock valuation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 100.0% | $-33.52 Million | $-33.51 Million | $5.40 Million | $38.93 Million | ▲ +76.6 pp |
| 2022 | 23.4% | $-2.48 Million | $-10.61 Million | $22.67 Million | $25.16 Million | ▼ -107.7 pp |
| 2021 | 131.1% | $75.17 Million | $57.32 Million | $83.46 Million | $8.29 Million | ▼ -260.2 pp |
| 2020 | 391.3% | $10.06 Million | $2.57 Million | $17.49 Million | $7.43 Million | — |